Anti-OX40L (Oxelumab), Human IgG1 Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P23510 |
---|---|
Reactivity | Human |
Host | Recombinant |
Clonality | Monoclonal |
Isotype | Human IgG1, kappa |
Calculated MW | 21050 Da |
Gene ID | 7292 |
---|---|
Alias Symbol | OX40L |
Other Names | TNFSF4; tumor necrosis factor (TNF) superfamily member 4; OX40 ligand; OX-40L; TAX transcriptionally-activated glycoprotein 1; TXGP1; gp34; CD252 |
Appearance | Colorless liquid |
Formulation | 200 µg affinity purified human antibody in phosphate-buffered saline (PBS) containing 0.02% Proclin 300 |
Reconstitution & Storage | -20 °C |
Background Descriptions | |
Precautions | Anti-OX40L (Oxelumab), Human IgG1 Antibody is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | TNFSF4 |
---|---|
Synonyms | TXGP1 |
Function | Cytokine that binds to TNFRSF4. Co-stimulates T-cell proliferation and cytokine production. |
Cellular Location | Membrane; Single-pass type II membrane protein. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
OX40 is also known as CD134 is a member of the tumor necrosis factor receptor superfamily (TNFR). OX40 plays an important role in CD4+ and CD8+T-cells and B-cells response. Binding of OX40 to its ligand, OX40L provides co-stimulatory signal to effector T-cells without CD28 activation.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.